Isaac Blech - InspireMD Vice Chairman of the Board
| NSPR Stock | USD 1.95 0.01 0.52% |
Chairman
Mr. Isaac Blech is Independent Vice Chairman of the Boardof the Company. He is a renowned biotechnology entrepreneur and investor, who, over the past 32 years, has founded and served on the board of companies which have produced major advances in a broad array of diseases, including the diagnosis of chlamydia, herpes, syphilis and HIV, and the treatment of cystic fibrosis, sexual dysfunction, multiple myeloma and brain cancer. The companies he established include Celgene Corporation, ICOS Corporationrationration, Nova Pharmaceutical Corporationrationration, Pathogenesis Corporation and Genetics Systems Corporationrationration. Mr. Blechs current roles include director and founder of Cerecor, Inc., a public company developing new treatments for central nervous system disorders, director of ContraFect Corporation, a public infectious disease company, director of Medgenics, Inc., a public company creating new treatments for rare diseases, and vice chairman of Edge Therapeutics, Inc., a public company that treats lifethreatening neurological conditions. He is vice chairman of Centrexion Corporationrationration, a private company which is developing new modalities of pain control, vice chairman of Regenovation, Inc., a private company developing new ways to regenerate human tissue, vice chairman of X4 Pharmaceuticals, a private cancer immunology company, vice chairman of Sapience Therapeutics, a private oncology company and vice chairman of Aridis Pharmaceuticals, a private company with a product to treat pneumonia. He also serves as vice chairman of WaveGuide Corporationrationration, a private company developing the worlds smallest NMR machine, vice chairman of root9B Technologies, Inc., a public cyber security company, and vice chairman of The SpendSmart Payments Company, a public electronic rewards company. since 2016.
| Age | 65 |
| Tenure | 8 years |
| Address | 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832 |
| Phone | 972 3 6917691 |
| Web | https://www.inspiremd.com |
InspireMD Management Efficiency
The company has return on total asset (ROA) of (0.3656) % which means that it has lost $0.3656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7001) %, meaning that it created substantial loss on money invested by shareholders. InspireMD's management efficiency ratios could be used to measure how well InspireMD manages its routine affairs as well as how well it operates its assets and liabilities. As of 05/02/2024, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, InspireMD's Total Assets are relatively stable compared to the past year. As of 05/02/2024, Total Current Assets is likely to grow to about 46.4 M, while Non Currrent Assets Other are likely to drop slightly above 654.2 K.Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| Haim Siboni | Foresight Autonomous Holdings | 65 | |
| David Barker | Bionano Genomics | 76 | |
| James Bochnowski | Jaguar Animal Health | 74 | |
| Michael Gally | Foresight Autonomous Holdings | 57 | |
| Stephen DeFalco | Senseonics Holdings | 55 | |
Management Performance
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.37 |
InspireMD Leadership Team
Elected by the shareholders, the InspireMD's board of directors comprises two types of representatives: InspireMD inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InspireMD. The board's role is to monitor InspireMD's management team and ensure that shareholders' interests are well served. InspireMD's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InspireMD's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Loughlin, Independent Director | ||
| Roei Samuri, VP Operations | ||
| Eli Bar, Senior Vice President - Research and Development and Chief Technical Officer of InspireMD Ltd | ||
| Craig Shore, CFO, Chief Admin. Officer, Secretary and Treasurer | ||
| Campbell Rogers, Independent Director | ||
| Michael Berman, Independent Director | ||
| Marvin Slosman, CEO President | ||
| Sol Barer, Independent Chairman of the Board | ||
| Alan Milinazzo, CEO and President and Director | ||
| Agustin Gago, Executive Vice President Chief Commercial Officer | ||
| Shane Gleason, Chief Officer | ||
| Thomas Kester, Director | ||
| Isaac Blech, Vice Chairman of the Board | ||
| DVM MD, Executive Affairs | ||
| Andrea Tommasoli, Chief Officer | ||
| Amir Kohen, Vice Resources | ||
| Pete Ligotti, Executive America | ||
| Paul Stuka, Independent Director | ||
| James Barry, COO, Executive VP and Director |
InspireMD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InspireMD a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.37 | ||||
| Operating Margin | (3.30) % | ||||
| Current Valuation | 8.08 M | ||||
| Shares Outstanding | 23.42 M | ||||
| Shares Owned By Insiders | 20.18 % | ||||
| Shares Owned By Institutions | 43.16 % | ||||
| Number Of Shares Shorted | 92.69 K | ||||
| Price To Earning | (0.16) X | ||||
| Price To Book | 1.38 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InspireMD in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InspireMD's short interest history, or implied volatility extrapolated from InspireMD options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for InspireMD Stock analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 0.256 | Quarterly Revenue Growth 0.716 | Return On Assets (0.37) | Return On Equity (0.70) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.